Drugs / Wulingsan co-decoction granules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04812236 | Apr 2021 → Feb 2023 | metabolic syndrome X | Jiangsu Famous Medical Technology Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Wulingsan co-decoction granules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04812236 ↗ |